Latest Company Leadership News

ClearVue Technologies has responded to ASX concerns after its CEO described previous project pipeline announcements as ‘fairy tales,’ affirming prior disclosures were accurate despite some project setbacks.

Beonic Limited has raised A$3.74 million through convertible notes, anchored by its largest shareholder, to accelerate growth, refinance debt, and support a major North African project.

Alkane Resources has completed its merger with Mandalay Resources, creating a dual-listed gold and antimony producer with a robust growth pipeline and a strong cash position.

Acrux Limited reports promising revenue growth driven by new topical generic launches in the US and secures crucial RDTI funding, marking a strategic shift under new CEO John Warmbrunn.

Cuscal Limited announces the retirement of long-serving CFO Sean O’Donoghue in late 2025 and the appointment of Jennifer Brice as his successor, signaling a seamless leadership transition as the company remains on track to meet its FY25 forecasts.

Catalina Resources has reported significant exploration progress with multiple high-grade gold and rare earth intercepts at its Central Yilgarn and Laverton Projects, alongside strategic leadership changes and a successful capital raise.

Victory Metals has significantly enhanced its North Stanmore resource with Gallium inclusion and secured major financing commitments exceeding US$200 million, positioning itself as a strategic supplier amid global rare earths tensions.

Topco, the newly proposed ASX-listed entity from the merger of Soul Patts and Brickworks, has secured full equity funding of approximately $1.4 billion, setting the stage for the merger’s next phase.

Topco, the new ASX-listed entity formed by the merger of Washington H. Soul Pattinson and Brickworks, has secured full equity funding of approximately $1.4 billion, setting the stage for the merger's next phase.

Noumi Limited has received Victorian Supreme Court approval for its $43 million class action settlement, closing a significant chapter tied to past financial restatements. The company’s insurer will cover its $11.56 million contribution, while legal costs will impact FY25 results.

Recce Pharmaceuticals has completed a A$15.8 million capital raise to fund pivotal Phase 3 clinical trials and progress its FDA application, positioning the company for potential commercial breakthroughs in antibiotic-resistant infections.

Victory Metals Limited has raised $4 million in a placement supported by top shareholders and company leadership, aiming to fast-track the Pre-Feasibility Study and development of its flagship North Stanmore Heavy Rare Earth Project in Western Australia.